Selected Publications

2026

  • Batista-Malat E, Wilbur K, Keller MS. Home- and community-based services use is not associated with lower elder abuse likelihood. JAMDA. Accepted July 2026.

  • Pevnick J, Kennelty K, Amer K, Berdahl C, Cook-Wiens G, Fanikos J, Fiskio J, Gotanda H, Guan J, Henreid A, Keller M, et al. Pharmacist Discharge Care (PHARM-DC) to reduce post-discharge utilization: multisite randomized controlled trial. JAMA Network Open. 2026. In press.

  • Keller MS, Mays AM, Hoang H, Rosen S. Improving geriatric follow-up after fall risk screening: a quality improvement initiative in primary care after the Medicare Annual Wellness Visit. Journal of the American Geriatrics Society. 2026;1–10. doi:10.1111/jgs.70504

  • Keller MS, Nguyen A, Leder C, Chen Y, Morse B, Schilling L, Hu D, SooHoo S, Ohno-Machado L. Exploring patient motivations and preferences for medical data sharing with researchers: a simulation study using the iAgree platform. JAMIA. 2026;ocag060. doi:10.1093/jamia/ocag060

  • SooHoo S, Keller M, Chen Y, Hu D, Huang SC, Kuo TT, et al. Development of the authentication and authorization processes for the iAgree Portal. JAMIA Open. 2026. doi:10.1093/jamiaopen/ooag111

  • Friedman SA, Guo Y, Owen AL, Chien LC, Woodard S, Keller MS. Clinician-level variation in MAUD prescribing: the role of behavioral health specialists in Nevada Medicaid. Journal of Behavioral Health Services and Research. In press.

2025

  • Bhagat M, Puga C, Keller MS. Interventions to optimize medication management in patients with language and health literacy barriers: a scoping review. Research in Social and Administrative Pharmacy. 2025.

  • Keller MS, Roberts P, Japardi K, Ebinger JE, Davis T, Pevnick J, et al. The Honest Enterprise Research Broker: facilitating ethical, efficient, and secure access to health data for research. Applied Clinical Informatics. 2025;16:362–368.

  • Friedman SA, Snyder P, Patterson D, Hartzell SY, Keller M. De-prescribing opioids among Medicaid patients with long-term opioid use. Journal of Substance Use and Addiction Treatment. 2025.

  • Hartzell SYT, Albertson EM, Friedman S, Keller MS. Trajectories of prescription opioid use for low back pain patients. Pain Practice. 2025;25:e70046.

  • Lu X, Hu D, Nguyen AT, Morse B, Schilling LM, Zheng K, Keller MS, Ohno-Machado L, Chen Y. We need granular sharing of de-identified data — but will patients engage? Proc ACM Hum-Comput Interact. 2025;10(2):CSCW043:1–33.

2024

  • Keller MS, Qureshi N, Mays AM, Sarkisian CA, Pevnick JM. Cumulative update of a systematic overview evaluating interventions addressing polypharmacy. JAMA Network Open. 2024;7(1):e2350963.

  • Keller MS, Guevara N, Guerrero JA, Mays AM, McCleskey SG, Reyes CE, Sarkisian CA. Experiences managing behavioral symptoms among Latino caregivers of Latino older adults with dementia and memory problems: a qualitative study. BMC Geriatrics. 2024;24(1):725.

  • Le TM, Campbell S, Andraos A, Ahlmark P, Hoang H, Isserman S, Goldzweig CL, Mays AM, Bradley K, Keller MS. Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials. BMJ Open. 2024;14(4):e080109.

  • Tantipinichwong N, Keller MS. Operation Polypharmacy: a pharmacist-led ambulatory care clinic design and evaluation for older patients. Scientific Reports. 2024;14(1):31719.

  • Oche O, Murry LT, Keller MS, Pevnick JM, Schnipper JL, Nguyen AT, Ko EM, Kennelty KA. Pharmacist, nurse, and physician perspectives on the implementation of the PHARM-DC intervention: a qualitative study. Research in Social and Administrative Pharmacy. 2024.

2023

  • Silva Almodovar A,* Keller MS,* Lee V, Mehta HB, Manja V, et al. Deprescribing medications among patients with multiple prescribers: a socioecological model. Journal of the American Geriatrics Society. 2023;1–10. (*co-first authors)

  • Keller MS, Carrascoza-Bolanos J, Breda K, Kim LY, Kennelty KA, et al. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and COM-B Model. BMJ Open. 2023;13:e066234.

  • Qureshi N, Keller MS. Identifying implementation factors for the development, operation, and sustainment of ambulatory care pharmacy programs: a qualitative study. Journal of General Internal Medicine. 2023.

  • Morse B, Kim KK, Xu Z, Matsumoto CG, Schilling LM, Ohno-Machado L, Mak SS, Keller MS. Patient and researcher stakeholder preferences for use of electronic health record data. JAMIA. 2023.

2022

  • Keller MS, Vordenberg SE, Steinman MA. Moving deprescribing upstream. Journal of General Internal Medicine. 2022.

  • Breda K, Keller MS, Gotanda H, Beland A, McKelvey K, Lin C, Rosen S. Geriatric fracture program centering age-friendly care associated with lower length of stay and lower direct costs. Health Services Research. 2022.

  • Gregorian T, Bradley K, Campbell S, Mashburn R, Beuttler R, Keller MS. Design, implementation, and evaluation of a pharmacist-led outpatient benzodiazepine-tapering clinic. Journal of the American Pharmacists Association. 2022.